Albert Einstein College of Medicine Researchers Develop Promising New Cancer Therapy
/PRNewswire/ -- Immune checkpoint inhibitors such as Keytruda and Opdivo work by unleashing the immune system's T cells to attack tumor cells. Their...
Source: prnewswire.com
